USNA USANA Health Sciences, Inc. Common Stock

NYSE · Consumer products · Wyświetl na SEC EDGAR ↗
$12,96
Cena · Sie 18, 2026
Dane fundamentalne na dzień Sie 13, 2026

O USANA Health Sciences, Inc. Common Stock Przegląd firmy z Wikipedii

USANA Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.

Czytaj więcej

USANA Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.

History

In 1992, immunologist and microbiologist Myron Wentz moved his diagnostic testing company, Gull Laboratories, from Salt Lake City to West Valley City, Utah, and spun it into USANA Health Services, a multilevel marketing manufacturer of supplements. Beginning in 1993, Dallin A. Larsen served as USANA's vice president of sales (and later as a consultant to USANA's president and special advisor to the board of directors) before founding the MLM beverage company Monavie in 2005. USANA's products are not available through retail channels, and can only be obtained through one of its independent distributors (referred to as "associates") or by direct order through the company.

On 20 February 2007, Barry Minkow, founder of the Fraud Discovery Institute, distributed a 500-page report to officials at the U.S. Securities and Exchange Commission (SEC), the Federal Bureau of Investigation (FBI), and the Internal Revenue Service (IRS) accusing USANA of operating an illegal pyramid scheme. The SEC conducted an investigation into USANA's business practices in March 2007 and found no evidence of wrongdoing, concluding its inquiry with no enforcement action recommended. Minkow acknowledged that he was shorting USANA's shares, hoping to profit from a drop in the stock price. In April 2007, a class action lawsuit was filed alleging that USANA's common stock had been artificially inflated. In August 2007, USANA was notified by the Securities and Exchange Commission (SEC) that its shares were subject to delisting from the NASDAQ due to its Form 10-Q, and was determined to be in compliance that October.

In January 2008, a shareholder suit was filed with allegations that USANA had misled investors about the sustainability of its growth and business model. The cases were dismissed, and the company was cleared by the U.S. Securities and Exchange Commission after an informal inquiry into the allegations, stating that it did "not intend to recommend any enforcement action by the Commission." Later that year, two Canadian USANA distributors were awarded $7 million in damages for their wrongful dismissal from the company. The firm had terminated their positions in 2003 because it believed the distributor had violated the companies' policies and procedures.

USANA filed suits against Minkow and his company claiming defamation and stock manipulation. USANA dropped the defamation suit and in March 2008 U.S. District Judge Tena Campbell threw out four of the five claims brought by USANA against Minkow ruling that USANA's claims violated California's anti-SLAPP law for suing Minkow for fair criticism and that USANA did not show a reasonable probability of winning on those claims. The remaining charge of stock manipulation was settled in July 2008, when USANA and Minkow reached an undisclosed settlement that included the removal of all USANA-related materials from the Fraud Discovery Institute website, a related Chinese website, and YouTube. Minkow also agreed to never trade in USANA's stock again.

In December 2010, USANA completed the application process to transfer its common stock listing from the NASDAQ National Market System, where it had traded since 1996, to the New York Stock Exchange. The transfer became official at the beginning of 2011. It received drug-establishment registration from the Food and Drug Administration to manufacture over-the-counter drugs later that year. In 2012, 91% of product sales were purchased by associates. The company acquired BabyCare Ltd., a China-based prenatal supplement company, in 2013 and announced plans to build a manufacturing facility in the country.

By 2018, USANA had reported record revenue due to growth in the Asia-Pacific region, though it recorded a 7% drop in net sales during its 2019 annual report. USANA has partnered with HealthCorps on health education for children and, in 2019, the USANA Foundation's Kids Eat program opened a facility to pack and distribute food for childhood hunger in the Utah area. It was also announced as the official nutritional partner of the Spartan Race endurance brand in the United States. Its sales for the first quarter of 2020 declined by 2.3 percent compared with 2019 numbers.

In February 2019, the Ministry of Commerce in China suspended operations of all multi-level marketing companies and participants to conduct a 100-day review of the country's health foods industry due to exaggerated advertising claims and questionable products in the unregulated sector. Chinese departments initiated "Hundred Days of Action" to clean up the health market, where 49 products from various companies were revoked, 54 food business licenses of various companies were revoked, 90 business licenses of various companies were revoked, and 465 counterfeit and fake dens were destroyed. 85 companies, including BabyCare Ltd., a USANA subsidiary, signed a declaration to self-discipline and regulate operations, with BabyCare speaking at an event hosted by the Chinese government.

Corporate affairs

Leadership

In 2007, USANA faced repeated controversy after members of its board of directors, medical advisory board and several of its executives made false statements regarding their qualifications, including education and licenses.

Founder Myron Wentz was the company's chief executive officer from 1992 until 2008, when his son, Dave Wentz, succeeded him after working in positions such as president, executive vice president, and senior vice president of strategic development. In 2015, USANA announced that the chief executive officer role would be divided between Wentz and Kevin Guest, with the former taking global operations and the latter, field development and sales. Guest was appointed the sole chief executive officer in November 2016.

Operations

USANA, a multilevel marketing company, sells its products primarily through non-employee distributors, known as sales "associates", as well as through the Internet. The firm's 2010 income disclosure statement defines "associates" as those who are actively building a business, acting as wholesale buyers, or are new distributors. The firm's 2009 SEC 10-K filing distinguishes between associates and preferred customers. Associates are independent distributors of USANA products and also purchase them for personal use. Preferred customers may purchase products at wholesale prices strictly for personal use and are not permitted to resell or distribute them. As of July 2011, the firm had 222,000 active Associates and 68,000 preferred customers. It manufactured 90% of its products at the Salt Lake City headquarters, which produced more than 22 million tablets each week.

Associates may be eligible to receive commissions based on their own product sales as well as through sales made by any new distributors they recruit. According to documentation from USANA corporate, 87 percent of associates fail to make enough from commissions to recover the cost of their qualifying purchases with 67 percent of all associates making no commission; the top 2.31 percent of associates earns 72.2 percent of the company's commissions. According to a 2011 article published by the Salt Lake City Tribune, the firm's FY09 income disclosure statement indicated that the average yearly income of the company's 165,710 associates, which includes those just starting, was $617, while the "top-of-the-pyramid distributors earn an average of $857,865 annually".

Sponsorships

USANA has been a paid sponsor of various athletic organizations. USANA offers an "Athlete Guarantee Program" to select sponsored athletes. The program permits selected participants to enter into an agreement with the company stipulating that, should an athlete enrolled in the program test positive for a banned substance (included in World Anti-Doping Agency regulations) as a result of taking USANA products, the company will compensate the athlete up to two times his or her current annual earnings up to $1 million USD.

In 2006, USANA signed a co-sponsorship agreement with the WTA Tour and extended it in 2011. The agreement provides athletes with nutritional supplements that are guaranteed to conform to the Tour's antidoping policy. As part of the agreement in 2011, USANA donated $1 to Children's Hunger Fund for every ace scored at a WTA tournament beginning at Wimbledon and continuing through the end of the season.

In 2003, USANA became the title sponsor of the USANA Amphitheatre, an outdoor amphitheatre based in West Valley City, Utah with a seating capacity of 20,000. In May 2012, United Concerts announced a continued naming rights partnership with USANA Health Sciences through March 2018.

In the lead-up to the 2020 Summer Olympics, USANA announced partnerships with USA Swimming and the USA Skateboarding National Team. It was the official multivitamin sponsor of USA Swimming and official nutritional supplement supplier of USA Skateboarding. The partnerships reportedly extended into multi-year agreements.

Products

USANA produces three product lines: USANA Nutritionals (Cellsentials, Optimizers, and Digestion/Detox nutritional supplements), USANA Diet & Energy (Reset meal replacement shakes, protein bars, and Rev3 energy drinks), and Sensé & Celavive personal care (skin care, skin treatment, and hair & body care products).

USANA Essentials were tested in 2011 by ConsumerLab.com in its Multivitamin and Multimineral Supplements Review of 38 leading multivitamin/multimineral products sold in the U.S. and Canada. The Essentials passed ConsumerLab's test, which included testing of selected index elements, their ability to disintegrate in solution per United States Pharmacopeia guidelines, lead contamination threshold set in California Proposition 65, and meeting U.S. Food and Drug Administration (FDA) labeling requirements.

As of 2019, its products are marketed in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, the United Kingdom, the Caribbean, Puerto Rico, Philippines, France, China, Spain, Italy, Germany, Romania, Denmark, Colombia and Indonesia.

Reception

From 2004 to 2006, USANA was named on Forbes "200 Best Small Companies" list. In 2007, a Forbes article quoted industry experts and government officials who had raised questions about the cost of USANA's supplements and its business practices. Radio-Canada later aired an investigative report that examined the company's products, pricing and "misleading income claims" made to potential associates concerning revenue. It included hidden-camera footage of recruitment and other sessions, which found one group of associates appeared to violate the company's policies and distributor agreements. This contrasted with the Canadian legal requirements for multi-level marketing companies to provide clear, frequent and complete information about the revenue of the typical participant. In addition, the same group of associates were filmed making recommendations for using USANA products to treat illnesses including leukemia.

John Cloud, senior writer for Time Magazine, evaluated nutritional supplements in which he took a regimen of USANA pills, protein bars, powder drinks and psyllium fiber as recommended by the company's online evaluation. Cloud took a blood test before starting the products to measure levels of calcium, protein, sodium, cholesterol, glucose, and other substances, and was then tested again five months after starting the supplement regimen, which included 3,000 pills at a cost of $1,200. The follow-up test revealed a change in only two values; a 75% increase in vitamin D levels (attributed to the vitamin D3 supplement Cloud had been taking) and a 28 mg/dl increase in high-density lipoprotein, which could not be accounted for. Cloud also experienced a placebo response where that act of taking the supplements made him feel more vigorous despite no physiological reasons being present. This response also led to a 10-lb weight gain, as the belief that he was more vigorous led him to make poorer dietary decisions—a phenomenon referred to as the "licensing effect".

New Zealand government statistician for the Commerce Commission, Murray H. Smith, who served as an expert witness in every pyramid scheme case brought by the Commission preceding 10 years, opined in 2008 that very few USANA distributors are likely to become wealthy, and stated, "you can make a very strong argument that this could be a pyramid scheme." When asked by the National Business Review to review the firm's business structure and compensation plan, it was Smith's opinion, from a statistical not legal standpoint, that the firm demonstrated a number of characteristics commonly occurring in pyramid schemes including that most members recoup less than what they pay to participate; that those at the top of the structure are more likely to make more than those on the bottom of the structure; and that as the company grows it will become harder to recruit others. Smith also noted the company's significant turnover in distributors making it necessary to continually recruit.

Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗

Wikidata ↗

USNA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy

Cena
$12.96
Kapitalizacja Rynkowa
$239M
P/E (TTM)
22.6
EPS (TTM)
$0.58
Przychody (TTM)
$925M
Stopa dywidendy
ROE
2.0%
D/E Dług/Kapitał
Zakres 52 tyg.
$13 – $32

USNA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok

Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS

Przychody i Zysk Netto $925M
10-point trend, -8.0%
2016-12-31 2026-01-03
EPS $0.58
10-point trend, -85.5%
2016-12-31 2026-01-03
Wolny przepływ pieniężny $9M
10-point trend, -91.8%
2016-12-31 2026-01-03
Marże 1.2%
10-point trend, -4.6%
2016-12-31 2026-01-03

Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?

Wskaźnik
Trend 5-letni
USNA
Mediana porównawcza
P/E (TTM)
5-point trend, +89.8%
22.6
15.6
P/S (TTM)
5-point trend, -76.8%
0.3
0.6
P/B
5-point trend, -86.6%
0.4
2.6
Price / FCF (Cena / FCF)
5-point trend, +130.4%
28.1

Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC

Wskaźnik
Trend 5-letni
USNA
Mediana porównawcza
Gross Margin (Marża brutto)
5-point trend, -4.1%
78.3%
69.1%
Operating Margin (Marża Operacyjna)
5-point trend, -71.8%
4.0%
Net Profit Margin (Marża Zysku Netto)
5-point trend, -88.2%
1.2%
3.9%
ROA
5-point trend, -92.5%
1.4%
5.0%
ROE
5-point trend, -93.1%
2.0%
9.6%
ROIC
5-point trend, -93.4%
1.9%

Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu

Wskaźnik
Trend 5-letni
USNA
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
5-point trend, -1.2%
2.2
2.5
Quick Ratio (Wskaźnik Szybkości)
5-point trend, -17.4%
1.2

Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni

Wskaźnik
Trend 5-letni
USNA
Mediana porównawcza
Revenue YoY (Przychody R/R)
5-point trend, -22.0%
8.3%
Revenue CAGR 3Y (Przychody CAGR 3L)
5-point trend, -22.0%
-2.5%
Revenue CAGR 5Y (Przychody CAGR 5L)
5-point trend, -22.0%
-4.0%
EPS YoY
5-point trend, -89.9%
-73.5%
Net Income YoY (Zysk Netto R/R)
5-point trend, -90.8%
-74.4%

Wskaźniki na akcję EPS, wartość księgowa na akcję, przepływy pieniężne na akcję, dywidenda na akcję

Wskaźnik
Trend 5-letni
USNA
Mediana porównawcza
EPS (Diluted) (EPS (Rozwodniony))
5-point trend, -89.9%
$0.58

Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności

Wskaźnik
Trend 5-letni
USNA
Mediana porównawcza

USNA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu

SPRZEDAJ 6 analityków
  • Mocne kupno 0 0,0%
  • Kup 0 0,0%
  • Trzymaj 3 50,0%
  • Sprzedaj 1 16,7%
  • Mocna sprzedaż 2 33,3%

12-miesięczny cel cenowy

1 analityków · 2026-08-14
Średni cel $25.00 +92,8%
Średnia cel $25.00 +92,8%

Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników

Średnie zaskoczenie
-0.10%
Okres EPS Actual EPS Szacowany Niespodzianka
30 czerwca 2026 $-0.07 $0.44 -0.51%
31 marca 2026 $0.61 $0.45 0.16%
31 grudnia 2025 $0.60 $0.42 0.18%
30 września 2025 $-0.15 $0.48 -0.63%
30 czerwca 2025 $0.74 $0.55 0.19%
31 marca 2025 $0.73 $0.71 0.02%

Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora

Ticker Kapitalizacja Rynkowa P/E Przychody r/r Marża Netto ROE Marża brutto
USNA $355M 33.5 8.3% 1.2% 2.0% 78.3%
BRBR $4.39B 21.6 16.1% 9.3% -72.0% 33.3%
HNST $291M -18.4 -1.9% -4.2% -8.8% 33.3%
NATR $378M 20.4 5.7% 4.1% 12.0% 72.4%
NAGE $507M 31.8 29.9% 13.4% 24.7% 64.3%
NUS 3.0 -14.3% 10.8% 22.0% 69.5%
MED $117M -6.3 -36.0% -4.8% -9.0% 71.3%

Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne

Rachunek zysków i strat 18
Dane roczne Rachunek zysków i strat dla USNA
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +17.1% $925M $855M $921M $999M $1.19B $1.13B $1.06B $1.19B $1.05B $1.01B $918M $790M
Cost of Revenue 12-point trend, +42.7% $201M $161M $177M $194M $218M $209M $188M $201M $179M $180M $160M $141M
Gross Profit 12-point trend, +11.5% $724M $693M $744M $805M $969M $926M $873M $989M $868M $826M $759M $650M
R&D Expense 12-point trend, +108.5% $11M $12M $11M $12M $11M $11M $10M $10M $9M $9M $6M $5M
SG&A Expense 12-point trend, +82.8% $337M $263M $257M $262M $279M $261M $268M $275M $265M $234M $209M $185M
Operating Expenses 12-point trend, +28.7% $687M $627M $651M $697M $798M $749M $727M $800M $735M $687M $617M $534M
Operating Income 12-point trend, -67.8% $37M $66M $93M $108M $170M $176M $146M $188M $133M $139M $142M $116M
Interest Expense 10-point trend, +103.1% · · $262.0K $192.0K $57.0K $507.0K $66.0K $36.0K $46.0K $444.0K $15.0K $129.0K
Interest Income 12-point trend, +383.0% $2M $11M $10M $4M $3M $3M $5M $4M $2M $1M $1M $500.0K
Other Non-op 12-point trend, +407.6% $3M $-1M $7.0K $-3M $-2M $-571.0K $-335.0K $-1M $-3.0K $-1M $-174.0K $-820.0K
Pretax Income 12-point trend, -64.1% $42M $76M $102M $109M $171M $178M $150M $192M $135M $139M $143M $116M
Income Tax 12-point trend, -23.0% $30M $34M $39M $39M $54M $53M $50M $65M $72M $39M $48M $39M
Net Income 12-point trend, -86.0% $11M $42M $64M $69M $117M $125M $101M $126M $63M $100M $95M $77M
EPS (Basic) 12-point trend, -80.0% $0.58 $2.20 $3.31 $3.60 $5.78 $5.89 $4.44 $5.24 $2.57 $4.14 $3.72 $2.90
EPS (Diluted) 12-point trend, -79.3% $0.58 $2.19 $3.30 $3.59 $5.73 $5.86 $4.41 $5.12 $2.53 $3.99 $3.59 $2.80
Shares (Basic) 12-point trend, -29.9% 18,535,000 19,103,000 19,250,000 19,254,000 20,146,000 21,156,000 22,644,000 24,105,000 24,349,000 24,185,000 25,460,000 26,443,000
Shares (Diluted) 12-point trend, -32.2% 18,574,000 19,162,000 19,345,000 19,310,000 20,343,000 21,256,000 22,818,000 24,642,000 24,708,000 25,047,000 26,355,000 27,377,000
EBITDA 12-point trend, -44.0% $70M $81M $106M $121M $183M $190M $161M $205M $149M $152M $152M $125M
Bilans 26
Dane roczne Bilans dla USNA
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +42.5% $158M $182M $330M $288M $240M $312M $235M $214M $247M $176M $143M $111M
Receivables $4M · · · · · · · · · · ·
Inventory 12-point trend, +126.8% $103M $70M $61M $67M $98M $90M $69M $82M $63M $65M $66M $45M
Prepaid Expense 12-point trend, -33.1% $23M $28M $26M $29M $27M $23M $26M $33M $30M $37M $35M $35M
Other Current Assets 12-point trend, -13.7% $5M $5M $6M $7M $4M $5M $5M $7M $5M $6M $5M $6M
Current Assets 12-point trend, +51.1% $288M $279M $418M $384M $365M $425M $329M $392M $340M $278M $244M $191M
PP&E (Net) 12-point trend, +32.6% $94M $95M $100M $98M $102M $100M $95M $92M $103M $101M $88M $71M
PP&E (Gross) 10-point trend, +86.4% · · $212M $210M $211M $199M $181M $178M $177M $164M $120M $114M
Accum. Depreciation 12-point trend, +109.1% $135M $130M $129M $125M $122M $116M $105M $96M $86M $76M $71M $64M
Goodwill 12-point trend, +669.0% $138M $144M $17M $17M $18M $17M $17M $17M $17M $17M $17M $18M
Intangibles 12-point trend, +225.1% $133M $152M $30M $32M $30M $31M $30M $32M $35M $34M $38M $41M
Other Non-current Assets 12-point trend, +161.1% $62M $59M $55M $55M $58M $62M $43M $18M $21M $22M $25M $24M
Total Assets 12-point trend, +111.9% $743M $748M $633M $597M $578M $641M $517M $554M $519M $471M $423M $351M
Accounts Payable 12-point trend, +121.9% $17M $12M $10M $11M $14M $18M $13M $10M $12M $9M $10M $8M
Accrued Liabilities 3-point trend, -2.6% $10M $14M $10M · · · · · · · · ·
Current Liabilities 12-point trend, +18.3% $129M $140M $119M $144M $161M $168M $136M $149M $141M $138M $131M $109M
Capital Leases 6-point trend, -28.8% $12M $10M $5M $8M $10M · $17M · · · · ·
Deferred Tax 12-point trend, -53.9% $5M $4M $5M $4M $7M $12M $10M $13M $14M $5M $10M $11M
Other Non-current Liabilities 12-point trend, +1981.3% $23M $18M $12M $14M $14M $19M $19M $1M $1M $1M $1M $1M
Total Liabilities 3-point trend, +15.6% $157M $162M $136M · · · · · · · · ·
Common Stock 12-point trend, +38.5% $18.0K $19.0K $19.0K $19.0K $19.0K $21.0K $22.0K $24.0K $24.0K $24.0K $25.0K $13.0K
Retained Earnings 12-point trend, +179.9% $466M $479M $445M $392M $345M $383M $306M $330M $288M $265M $215M $166M
AOCI 12-point trend, -858.8% $-16M $-23M $-14M $-13M $458.0K $-4M $-14M $-10M $-1M $-12M $-4M $2M
Stockholders' Equity 12-point trend, +131.6% $533M $532M $497M $434M $395M $442M $352M $391M $363M $325M $281M $230M
Liabilities + Equity 12-point trend, +111.9% $743M $748M $633M $597M $578M $641M $517M $554M $519M $471M $423M $351M
Shares Outstanding 12-point trend, -27.6% 18,281,000 19,064,000 19,130,000 19,206,000 19,393,000 21,038,000 21,655,000 23,567,000 24,024,000 24,485,000 24,976,000 25,266,000
Przepływy pieniężne 16
Dane roczne Przepływy pieniężne dla USNA
Wskaźnik Trend 202520242023202220212020201920182017201620152014
D&A 12-point trend, +269.6% $33M $15M $13M $13M $13M $14M $15M $17M $16M $13M $10M $9M
Stock-based Comp 12-point trend, +41.0% $14M $15M $15M $13M $14M $14M $16M $15M $15M $17M $11M $10M
Deferred Tax 12-point trend, -586.8% $-7M $-7M $-3M $-7M $-3M $-2M $-4M $607.0K $19M $-4M $-3M $-1M
Amort. of Intangibles 12-point trend, +4382.1% $19M $2M $2M $2M $1M $1M $1M $2M $1M $2M $900.0K $431.0K
Restructuring 3-point trend, +6463000.00 $6M $0 $0 · · · · · · · · ·
Other Non-cash 12-point trend, -352.1% $-28M $-3M $-18M $15M $-20M $10M $-442.0K $-7M $10M $11M $-2M $11M
Operating Cash Flow 12-point trend, -78.8% $22M $61M $71M $104M $121M $160M $127M $152M $124M $137M $111M $105M
CapEx 12-point trend, -32.3% $14M $10M $14M $10M $13M $15M $17M $11M $13M $33M $24M $20M
Investing Cash Flow 12-point trend, +37.8% $-10M $-213M $-12M $-12M $-14M $-34M $47M $-69M $-13M $-32M $-25M $-16M
Stock Repurchased 12-point trend, -80.2% $28M $9M $12M $25M $178M $57M $150M $105M $50M $65M $61M $139M
Net Stock Activity 12-point trend, +80.2% $-28M $-9M $-12M $-25M $-178M $-57M $-150M $-105M $-50M $-65M $-61M $-139M
Financing Cash Flow 12-point trend, +64.1% $-41M $10M $-14M $-30M $-181M $-59M $-152M $-105M $-50M $-65M $-49M $-113M
Net Change in Cash 12-point trend, +11.2% $-23M $-149M $42M $48M $-72M $78M $20M $-33M $72M $32M $32M $-26M
Taxes Paid 3-point trend, -12.2% $37M $40M $42M · · · · · · · · ·
Free Cash Flow 12-point trend, -89.9% $9M $51M $56M $94M $108M $145M $110M $141M $111M $104M $88M $85M
Levered FCF 10-point trend, -33.9% · · $56M $93M $108M $145M $110M $141M $111M $104M $88M $85M
Rentowność 8
Dane roczne Rentowność dla USNA
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Gross Margin 12-point trend, -4.7% 78.3% 81.1% 80.8% 80.6% 81.6% 81.6% 82.3% 83.1% 82.9% 82.1% 82.6% 82.2%
Operating Margin 12-point trend, -72.4% 4.0% 7.8% 10.1% 10.8% 14.3% 15.6% 13.8% 15.8% 12.7% 13.8% 15.4% 14.7%
Net Margin 12-point trend, -88.0% 1.2% 4.9% 6.9% 6.9% 9.8% 11.0% 9.5% 10.6% 6.0% 9.9% 10.3% 9.7%
Pretax Margin 12-point trend, -69.3% 4.5% 8.9% 11.1% 10.9% 14.4% 15.7% 14.2% 16.1% 12.9% 13.8% 15.5% 14.6%
EBITDA Margin 12-point trend, -52.2% 7.6% 9.5% 11.5% 12.1% 15.4% 16.8% 15.2% 17.2% 14.2% 15.1% 16.5% 15.8%
ROA 12-point trend, -93.2% 1.4% 6.1% 10.4% 11.8% 19.1% 21.5% 18.8% 23.5% 12.6% 22.4% 24.5% 21.3%
ROE 12-point trend, -93.5% 2.0% 7.9% 13.2% 16.4% 29.3% 30.0% 30.2% 30.5% 17.2% 33.0% 37.0% 31.2%
ROIC 12-point trend, -94.2% 1.9% 6.9% 11.7% 15.8% 29.4% 28.0% 27.8% 31.7% 16.9% 30.8% 33.5% 33.4%
Płynność i wypłacalność 3
Dane roczne Płynność i wypłacalność dla USNA
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, +27.7% 2.2 2.0 3.5 2.7 2.3 2.5 2.4 2.6 2.4 2.0 1.9 1.8
Quick Ratio 12-point trend, +20.5% 1.2 1.3 2.8 2.0 1.5 1.9 1.7 1.4 1.8 1.3 1.1 1.0
Interest Coverage 10-point trend, -60.5% · · 355.2 560.5 2985.8 348.1 2215.0 5232.0 2880.5 312.2 9444.1 900.0
Efektywność 2
Dane roczne Efektywność dla USNA
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Asset Turnover 12-point trend, -43.6% 1.2 1.2 1.5 1.7 1.9 2.0 2.0 2.2 2.1 2.3 2.4 2.2
Inventory Turnover 12-point trend, -23.4% 2.3 2.5 2.7 2.3 2.3 2.2 2.5 2.8 2.8 2.8 2.9 3.0
Na akcję 5
Dane roczne Na akcję dla USNA
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, +60.1% $29.16 $27.91 $25.99 $22.62 $20.37 $20.99 $16.24 $16.60 $15.12 $13.29 $22.49 $18.22
Revenue / Share 12-point trend, -13.7% $49.81 $44.59 $47.61 $51.71 $58.32 $53.38 $46.49 $48.26 $42.39 $40.17 $69.70 $57.74
Cash Flow / Share 12-point trend, -84.3% $1.20 $3.18 $3.65 $5.38 $5.96 $7.55 $5.55 $6.17 $5.01 $5.47 $8.46 $7.68
Cash / Share 12-point trend, -1.5% $8.66 $9.53 $17.27 $15.02 $12.37 $14.83 $10.84 $9.09 $10.29 $7.18 $11.47 $8.80
EPS (TTM) 12-point trend, -79.3% $0.58 $2.19 $3.30 $3.59 $5.73 $5.86 $4.41 $5.12 $2.53 $3.99 $3.59 $2.80
Stopy Wzrostu 9
Dane roczne Stopy Wzrostu dla USNA
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, +81.2% 8.3% -7.2% -7.8% -15.8% 4.6% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +62.6% -2.5% -10.4% -6.7% · · · · · · · · ·
Revenue CAGR 5Y -4.0% · · · · · · · · · · ·
EPS YoY 5-point trend, -3211.7% -73.5% -33.6% -8.1% -37.4% -2.2% · · · · · · ·
EPS CAGR 3Y 3-point trend, -161.4% -45.5% -27.4% -17.4% · · · · · · · · ·
EPS CAGR 5Y -37.0% · · · · · · · · · · ·
Net Income YoY 5-point trend, -1037.6% -74.4% -34.1% -8.0% -40.5% -6.5% · · · · · · ·
Net Income CAGR 3Y 3-point trend, -131.1% -46.3% -28.8% -20.0% · · · · · · · · ·
Net Income CAGR 5Y -38.7% · · · · · · · · · · ·
Wycena (TTM) 10
Dane roczne Wycena (TTM) dla USNA
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +17.1% $925M $855M $921M $999M $1.19B $1.13B $1.06B $1.19B $1.05B $1.01B $918M $790M
Net Income TTM 12-point trend, -86.0% $11M $42M $64M $69M $117M $125M $101M $126M $63M $100M $95M $77M
Market Cap 12-point trend, -45.0% $355M $680M $1.03B $1.02B $1.96B $1.62B $1.73B $2.71B $1.78B $1.50B $798M $646M
P/E 12-point trend, +83.5% 33.5 16.3 16.2 14.8 17.7 13.2 18.1 22.5 29.3 15.3 17.8 18.3
P/S 12-point trend, -53.0% 0.4 0.8 1.1 1.0 1.7 1.4 1.6 2.3 1.7 1.5 0.9 0.8
P/B 12-point trend, -76.3% 0.7 1.3 2.1 2.4 5.0 3.7 4.9 6.9 4.9 4.6 2.8 2.8
P / Tangible Book 6-point trend, -67.1% 1.4 2.9 2.3 2.7 5.7 4.1 · · · · · ·
P / Cash Flow 12-point trend, +158.9% 15.9 11.2 14.5 9.8 16.2 10.1 13.7 17.8 14.4 10.9 7.2 6.1
P / FCF 12-point trend, +446.9% 41.7 13.4 18.3 10.9 18.1 11.2 15.7 19.3 16.1 14.4 9.1 7.6
Earnings Yield 12-point trend, -45.6% 3.0% 6.1% 6.2% 6.8% 5.7% 7.6% 5.5% 4.5% 3.4% 6.5% 5.6% 5.5%

Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat

Rachunek zysków i strat
2026-01-032024-12-282023-12-302022-12-312022-01-01
Przychody $925M$855M$921M$999M$1.19B
Marża Brutto % 78.3%81.1%80.8%80.6%81.6%
Marża Operacyjna % 4.0%7.8%10.1%10.8%14.3%
Zysk netto $11M$42M$64M$69M$117M
Rozwodniony EPS $0.58$2.19$3.30$3.59$5.73
Bilans
2026-01-032024-12-282023-12-302022-12-312022-01-01
Wskaźnik bieżący 2.22.03.52.72.3
Wskaźnik Szybkości 1.21.32.82.01.5
Przepływy pieniężne
2026-01-032024-12-282023-12-302022-12-312022-01-01
Wolny przepływ pieniężny $9M$51M$56M$94M$108M

Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów

📊

Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.

Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.

Właściciele instytucjonalni (13F) 152 emitenci · $176.6M łącznie · Na dzień 30 czerwca 2026

Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.

Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
Nowe pozycje Zamknięte pozycje Zwiększone Zmniejszony Zmiana liczby akcji netto
30 (+4 vs poprzedni kw.) 16 (+6 vs poprzedni kw.) 48 (+5 vs poprzedni kw.) 34 (-7 vs poprzedni kw.) +1.1M

Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.

Instytucja Wartość Akcje % z śledzonych 13F Typ
PZENA INVESTMENT MANAGEMENT LLC $25 739 282 1 205 587 14,58% Akcje
RENAISSANCE TECHNOLOGIES LLC $20 464 402 958 520 11,59% Akcje
Nantahala Capital Management, LLC $17 295 080 810 074 9,80% Akcje
DIMENSIONAL FUND ADVISORS LP $16 958 134 794 292 9,61% Akcje
VANGUARD CAPITAL MANAGEMENT LLC $10 405 350 487 370 5,89% Akcje
VANGUARD PORTFOLIO MANAGEMENT LLC $7 758 099 363 377 4,39% Akcje
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $5 811 641 272 208 3,29% Akcje
STATE STREET CORP $5 577 474 261 240 3,16% Akcje
GEODE CAPITAL MANAGEMENT, LLC $5 175 448 242 342 2,93% Akcje
AMERICAN CENTURY COMPANIES INC $3 999 880 187 348 2,27% Akcje
JACOBS LEVY EQUITY MANAGEMENT, INC $3 855 105 180 567 2,18% Akcje
TWO SIGMA INVESTMENTS, LP $3 533 724 165 514 2,00% Akcje
D. E. Shaw & Co., Inc. $3 348 427 156 835 1,90% Akcje
Allianz Asset Management GmbH $3 040 219 142 399 1,72% Akcje
BRIDGEWAY CAPITAL MANAGEMENT, LLC $2 949 567 138 153 1,67% Akcje
ALGERT GLOBAL LLC $2 813 033 131 758 1,59% Akcje
UBS Group AG $2 474 166 115 886 1,40% Akcje
BlackRock, Inc. $2 353 005 110 211 1,33% Akcje
LAZARD ASSET MANAGEMENT LLC $2 077 590 97 311 1,18% Akcje
VANGUARD FIDUCIARY TRUST CO $1 549 540 72 578 0,88% Akcje
Vanguard Global Advisers, LLC $1 514 569 70 940 0,86% Akcje
Empowered Funds, LLC $1 499 902 70 253 0,85% Akcje
AMERIPRISE FINANCIAL INC $1 443 624 67 617 0,82% Akcje
TWO SIGMA ADVISERS, LP $1 289 691 65 700 0,73% Akcje
GOLDMAN SACHS GROUP INC $1 121 921 52 549 0,64% Akcje
Quantinno Capital Management LP $1 072 261 50 223 0,61% Akcje
BANK OF AMERICA CORP /DE/ $967 539 45 318 0,55% Akcje
ROYCE & ASSOCIATES LP $884 039 41 407 0,50% Akcje
DEUTSCHE BANK AG\ $821 975 38 500 0,47% Akcje
Assenagon Asset Management S.A. $815 848 38 213 0,46% Akcje
BARCLAYS PLC $769 220 36 029 0,44% Akcje
STRS OHIO $723 765 33 900 0,41% Akcje
Skopos Labs, Inc. $673 696 38 563 0,38% Akcje
HSBC HOLDINGS PLC $672 758 31 960 0,38% Akcje
Bank of New York Mellon Corp $668 447 31 309 0,38% Akcje
XTX Topco Ltd $625 320 29 289 0,35% Akcje
MILLENNIUM MANAGEMENT LLC $570 728 26 732 0,32% Akcje
CITADEL ADVISORS LLC $569 639 26 681 0,32% Akcje
Verdad Advisers, LP $556 552 26 068 0,32% Akcje
Sanctuary Advisors, LLC $497 113 23 284 0,28% Akcje
Man Group plc $489 854 22 944 0,28% Akcje
State of Tennessee, Department of Treasury $461 160 21 600 0,26% Akcje
Point72 Asset Management, L.P. $397 238 18 606 0,22% Akcje
Unison Advisors LLC $384 300 18 000 0,22% Akcje
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO $384 215 17 996 0,22% Akcje
Numerai GP LLC $382 080 17 896 0,22% Akcje
KLP KAPITALFORVALTNING AS $375 760 17 600 0,21% Akcje
Connor, Clark & Lunn Investment Management Ltd. $366 836 17 182 0,21% Akcje
ALLIANCEBERNSTEIN L.P. $357 611 20 470 0,20% Akcje
CITADEL ADVISORS LLC $356 545 16 700 0,20% Opcja sprzedaży
Park Capital Management, LLC / WI $345 144 16 166 0,20% Akcje
Engineers Gate Manager LP $337 672 15 816 0,19% Akcje
SEGALL BRYANT & HAMILL, LLC $318 414 14 914 0,18% Akcje
RHUMBLINE ADVISERS $309 778 14 510 0,18% Akcje
Vanguard Personalized Indexing Management, LLC $309 724 14 507 0,18% Akcje
FIRST TRUST ADVISORS LP $308 998 14 473 0,18% Akcje
Toroso Investments, LLC $304 756 15 525 0,17% Akcje
EXCHANGE TRADED CONCEPTS, LLC $300 992 14 098 0,17% Akcje
IEQ CAPITAL, LLC $300 245 14 063 0,17% Akcje
Y-Intercept (Hong Kong) Ltd $298 366 13 975 0,17% Akcje
Focus Partners Wealth $292 794 13 714 0,17% Akcje
CITADEL ADVISORS LLC $273 280 12 800 0,15% Opcja kupna
BNP PARIBAS FINANCIAL MARKETS $263 160 12 326 0,15% Akcje
MERCER GLOBAL ADVISORS INC /ADV $243 881 11 423 0,14% Akcje
State of Wyoming $242 237 11 346 0,14% Akcje
ANCHYRA PARTNERS LLC $230 238 10 784 0,13% Akcje
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $229 982 10 772 0,13% Akcje
OCCUDO QUANTITATIVE STRATEGIES LP $226 652 10 616 0,13% Akcje
Mariner, LLC $219 915 10 302 0,12% Akcje
DGS Capital Management, LLC $207 876 11 899 0,12% Akcje
Cerity Partners LLC $141 913 6 647 0,08% Akcje
Magnetar Financial LLC $138 540 6 489 0,08% Akcje
MetLife Investment Management, LLC $124 236 5 819 0,07% Akcje
Russell Investments Group, Ltd. $123 637 5 791 0,07% Akcje
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $109 931 5 149 0,06% Akcje
Creative Planning $107 156 5 019 0,06% Akcje
FMR LLC $105 661 4 949 0,06% Akcje
SIGNATUREFD, LLC $101 391 4 749 0,06% Akcje
CWM, LLC $97 413 5 576 0,06% Akcje
VANGUARD GROUP INC $96 226 4 902 0,05% Akcje
Invesco Ltd. $95 072 4 453 0,05% Akcje
NEW YORK STATE COMMON RETIREMENT FUND $81 045 3 796 0,05% Akcje
Police & Firemen's Retirement System of New Jersey $73 935 3 463 0,04% Akcje
Parallel Advisors, LLC $70 818 3 317 0,04% Akcje
Farther Finance Advisors, LLC $41 873 1 964 0,02% Akcje
Arax Advisory Partners $40 588 1 901 0,02% Akcje
NATIONAL BANK OF CANADA /FI/ $40 499 1 896 0,02% Akcje
AlphaQuest LLC $38 259 1 949 0,02% Akcje
NORTHERN TRUST CORP $37 533 1 758 0,02% Akcje
OSAIC HOLDINGS, INC. $34 383 1 611 0,02% Akcje
LOM Asset Management Ltd $34 160 1 600 0,02% Akcje
Versant Capital Management, Inc $33 904 1 588 0,02% Akcje
MORGAN STANLEY $31 363 1 469 0,02% Akcje
Ameritas Investment Partners, Inc. $23 933 1 121 0,01% Akcje
Tower Research Capital LLC (TRC) $22 909 1 073 0,01% Akcje
Legal & General Group Plc $20 966 982 0,01% Akcje
Integrated Wealth Concepts LLC $18 833 882 0,01% Akcje
CITIGROUP INC $17 635 826 0,01% Akcje
Global Retirement Partners, LLC $14 433 676 0,01% Akcje
Allworth Financial LP $14 027 657 0,01% Akcje

Insiderzy spółki 38 insiderów · 20 dyrektorzy generalni · 13 dyrektorzy

Insider Rola Ostatnia aktywność Posiadane akcje Kupna 12m Sprzedaże 12m Netto 12m
Jim Brown CEO & PRESIDENT 24 lipca 2025 M 16 934 0 0 $0
Doug G Iiekking CHIEF FINANCIAL OFFICER 27 maja 2026 S 0 0 1 $-100 500
Jeffrey Yates Chief Financial Officer 28 października 2010 M 0 0 0 $0
Deborah Woo President of Asia 8 września 2016 M 1 479 0 0 $0
Fred W Cooper President and COO 28 października 2010 M 0 0 0 $0
Walter Noot CHIEF OPERATING OFFICER 19 lutego 2026 A 0 0 0 $0
Roy Truett Chief Operating Officer 27 lipca 2012 M 0 0 0 $0
Kathryn Michelle Armstrong CHIEF SCIENTIFIC OFFICER 25 lipca 2026 M 3 471 0 0 $0
Peter Benedict CHIEF INFORMATION OFFICER 25 lipca 2026 M 422 0 0 $0
Brent Neidig CHIEF COMMERCIAL OFFICER 16 czerwca 2026 S 0 0 3 $-147 749
Paul A. Jones CHIEF PEOPLE OFFICER 8 czerwca 2026 S 0 0 1 $-102 878
David Mulham Mulham CHIEF SALES OFFICER 30 lipca 2025 S 9 260 0 0 $0
Joshua Foukas CHIEF LEGAL OFFICER 12 marca 2025 S 0 0 0 $0
Daniel A. Macuga CHIEF COMMUNICATIONS OFFICER 2 maja 2024 S 0 0 0 $0
Robert A Sinnott CHIEF SCIENTIFIC OFFICER 5 marca 2024 S 0 0 0 $0
James Bramble Chief Legal Officer and Sec 5 lutego 2018 A 2 076 0 0 $0
Dave Wentz Co-C.E.O. 16 sierpnia 2016 M 384 883 0 0 $0
Rick Stambaugh Chief Information Officer 17 grudnia 2015 M 0 0 0 $0
Mark H Wilson E.V.P. of Sales 28 października 2010 M 5 000 0 0 $0
Bradford Richardson E.V.P. of Asia Pacific 25 lutego 2008 S 0 0 0 $0
Xia Ding Dyrektor 23 lipca 2026 M 8 278 0 0 $0
John Turman Fleming Dyrektor 23 lipca 2026 M 5 862 0 1 $-43 928
Peggie Pelosi Dyrektor 23 lipca 2026 M 6 061 0 0 $0
Scott J Nixon Dyrektor 23 lipca 2026 M 11 445 0 0 $0
Frederic J Winssinger Dyrektor 23 lipca 2026 M 9 733 0 0 $0
Timothy E Wood Dyrektor 23 lipca 2026 M 11 837 0 0 $0
Gilbert A Fuller Dyrektor 23 lipca 2026 M 1 632 0 3 $-60 414
Robert Auciaux Dyrektor 9 lutego 2022 M 436 0 0 $0
Feng Peng Dyrektor 28 kwietnia 2021 M 755 0 0 $0
Myron W. Wentz Dyrektor 4 lutego 2019 S 9 865 614 0 0 $0
Jerry G Mcclain Dyrektor 4 marca 2016 M 0 0 0 $0
Ronald S Poelman Dyrektor 8 lutego 2016 A 0 0 0 $0
Denis E Waitley Dyrektor 3 listopada 2006 M 0 0 0 $0
Gull Global Limited Posiadacz 10% 4 lutego 2019 S 9 865 614 0 0 $0
GULL HOLDINGS LTD Posiadacz 10% 1 kwietnia 2015 J 6 491 110 0 0 $0
Kevin Guest 27 lutego 2026 M 45 381 0 0 $0
Donald R. Williams 1 maja 2017 A 0 0 $0
Doug Braun 16 grudnia 2015 M 0 0 0 $0

Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S

Aktywiści i właściciele 5%+ 3 akcje

Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.

Zgłaszający Złożono Udział Status Cel Zgłoszenie
Gull Global Limited, Myron W. Wentz ×11 zgłoszenia 30 marca 2026 40,10% Aneks SEC
Gull Holdings, Ltd., Myron W. Wentz, David A. Wentz, Jacquelyn R. Wentz, Bryan Wentz, Annette Wentz, Paul & Jane Meyer Family Foundation, Paul James Meyer, Alice Jane Meyer, Centre Island Properties, Ltd., Waco Boys Club Foundation, Inc., L-K Marketing Group, LLC, Beagle Irrevocable Asset Trust 23 maja 2008 Pierwotne zgłoszenie SEC
Paul & Jane Meyer Family Foundation 20 maja 2008 Pierwotne zgłoszenie Inwestycja pasywna SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Posiadanie ETF-ów Posiadane przez 38 funduszy ETF

Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.

Fundusz Waga Jednostki Na dzień Źródło
DEEP · ETF Series Solutions 0,95% 13 646 NS 31 maja 2026 N-PORT
AFSM · First Trust Exchange-Traded Fund VI… 0,25% 13 206 NS 31 maja 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0,11% 45 046 SH 8 sierpnia 2026 Dziennie
EBIT · Harbor ETF Trust 0,06% 387 NS 30 kwietnia 2026 N-PORT
IWC · iShares Trust 0,04% 38 121 SH 8 sierpnia 2026 Dziennie
FNDA · SCHWAB STRATEGIC TRUST 0,03% 169 505 NS 31 maja 2026 N-PORT
VDC · VANGUARD WORLD FUND 0,03% 128 565 SH 8 sierpnia 2026 Dziennie
GSSC · Goldman Sachs ETF Trust 0,03% 15 259 NS 31 maja 2026 N-PORT
DFSV · Dimensional ETF Trust 0,02% 87 994 NS 30 kwietnia 2026 N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS 0,02% 9 639 SH 8 sierpnia 2026 Dziennie
DFAT · Dimensional ETF Trust 0,01% 97 080 NS 30 kwietnia 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0,01% 24 189 SH 8 sierpnia 2026 Dziennie
AVSC · AMERICAN CENTURY ETF TRUST 0,01% 18 642 NS 31 maja 2026 N-PORT
AVUV · AMERICAN CENTURY ETF TRUST 0,01% 159 569 NS 31 maja 2026 N-PORT
IWN · iShares Trust 0,01% 101 080 SH 8 sierpnia 2026 Dziennie
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 64 278 SH 8 sierpnia 2026 Dziennie
DFAS · Dimensional ETF Trust 0,01% 60 807 NS 30 kwietnia 2026 N-PORT
SMLF · iShares Trust 0,01% 22 748 SH 8 sierpnia 2026 Dziennie
OMFS · Invesco Exchange-Traded Self-Indexe… 0,01% 1 195 SH 8 sierpnia 2026 Dziennie
RSSL · Global X Funds 0,01% 4 685 NS 30 kwietnia 2026 N-PORT
IWM · iShares Trust 0,01% 283 211 SH 8 sierpnia 2026 Dziennie
ITWO · ProShares Trust 0,01% 508 NS 31 maja 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,00% 51 773 NS 31 maja 2026 N-PORT
FNDB · SCHWAB STRATEGIC TRUST 0,00% 2 158 NS 31 maja 2026 N-PORT
UWM · ProShares Trust 0,00% 397 NS 31 maja 2026 N-PORT
URTY · ProShares Trust 0,00% 406 NS 31 maja 2026 N-PORT
AVSU · AMERICAN CENTURY ETF TRUST 0,00% 247 NS 31 maja 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,00% 388 NS 31 maja 2026 N-PORT
HDG · ProShares Trust 0,00% 10 NS 31 maja 2026 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0,00% 5 468 NS 31 maja 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 19 278 NS 30 kwietnia 2026 N-PORT
ITOT · iShares Trust 0,00% 22 758 SH 8 sierpnia 2026 Dziennie
IWV · iShares Trust 0,00% 3 680 SH 8 sierpnia 2026 Dziennie
SCHB · SCHWAB STRATEGIC TRUST 0,00% 6 500 NS 31 maja 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 1 784 NS 30 kwietnia 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,00% 124 681 SH 8 sierpnia 2026 Dziennie
VTI · VANGUARD INDEX FUNDS 0,00% 350 035 SH 8 sierpnia 2026 Dziennie
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 790 SH 8 sierpnia 2026 Dziennie